← Back to all trials
Active Not Recruiting
NCT05232279
Effect of Testofen on Erectile Function in an Adult Male Population
Conditions: Erectile Dysfunction
Sex: Male
Ages: 40 Years – 75 Years
Healthy volunteers: No
Phase: PHASE3
Enrollment: 120
Sponsor: RDC Clinical Pty Ltd
Location: RDC Clinical Pty Ltd Brisbane Queensland
Summary
This is a double blind, randomised, placebo-controlled clinical study with a 12-week participation and 3 groups (2 active groups and 1 placebo group) designed to monitor erectile function symptom severity and the effect Testofen may have on improving erectile function, sexual function, and quality of life.
Eligibility Criteria
Inclusion Criteria:
* Healthy male adults aged 40-75 years
* Currently in a sexual relationship
* Males with reduced erectile function (Score of \14 alcoholic drinks week)
* Allergic to any of the ingredients in the active or placebo formula
* Any condition which in the opinion of the investigator makes the participant unsuitable for inclusion
* Participants who have participated in any other related clinical study during the past 1 month
a Any participant reporting having been told by their doctor that they have an under or over production of hormones (e.g., testosterone).
\*An unstable illness is any illness that is currently not being treated with a stable dose of medication or is fluctuating in severity. A serious illness is a condition that carries a risk of mortality, negatively impacts quality of life and daily function and/or is burdensome in symptoms and/or treatments.
Source: ClinicalTrials.gov (NCT05232279). StuddyBuddy aggregates publicly available trial information.